nily

This evaluation is not emergency care. If you have severe or persistent abdominal pain, repeated vomiting or cannot keep fluids down, major breathing difficulty, swelling of the face or throat, fainting, confusion, a seizure, immediate danger or another possible emergency in India, call 112 or go to the nearest emergency department. Do not wait for an appointment, app response or email.

Get a clinician-led evaluation before considering a GLP-1 weight-loss injection

Prescription weight-management medicines are not a shortcut selected by a quiz, an advertisement or a target number on the scale. Their potential benefits, limitations and risks depend on your health history, current medicines, previous efforts, goals, examination needs and the product's current approved use.

Nily helps you check whether an appropriately qualified clinician is available, review verified professional details, prepare relevant information and understand the evaluation fee, scope, possible outcomes and follow-up expectations before booking.

An assessment or consultation does not guarantee a prescription, particular medicine, dose, test, pharmacy fulfilment or weight-loss result.

Patient reviewing the scope of a clinician-led Nily GLP-1 and weight-management medicine evaluation

What is a GLP-1 clinical evaluation?

A GLP-1 clinical evaluation is a pre-prescription assessment—an individual consultation in which an appropriately qualified clinician reviews clinical suitability for a prescription weight-management medicine pathway, and what information, examination, monitoring or alternatives are needed. It does not diagnose, guarantee eligibility or replace an in-person assessment when one is required.

Start with the right pathway

What you need Relevant Nily pathway Important limit
Understand what to prepare for a consultation GLP-1 Readiness Check Non-diagnostic; cannot confirm suitability
Discuss prescription medicine suitability Check Clinical Evaluation Availability The clinician makes the individual decision
Build a broader weight-management plan Medical Weight Management Program Does not guarantee medicine or a result
Already have a current clinician-led plan GLP-1 Support Program Does not replace the prescriber
Need a general medical discussion Online Doctor Consultation Service scope and provider must match the concern
Need nutrition support within a plan Online Nutrition Consultation Nutrition professionals do not prescribe medicine unless separately qualified and authorized
Need baseline or follow-up laboratory testing Metabolic Laboratory Tests Testing must have a valid purpose and exact order

Explore All Health Services Explore Free Health Tools Explore the Metabolic Health Hub

What a GLP-1 clinical evaluation should consider

Your goals and prior weight-management experience

Discuss what you want to improve, what you have tried, what was sustainable and what created problems. The consultation must not reduce health to appearance or a single target weight.

Health history and current conditions

Review relevant metabolic, gastrointestinal, endocrine, kidney, liver, gallbladder, pancreatic and other history within the clinician's scope. Static public content must not decide which history excludes or permits a medicine.

Current medicines, supplements and allergies

Provide an accurate list, including previous weight-management medicines and relevant reactions. The clinician considers interactions, duplication, administration and monitoring needs.

Pregnancy, breastfeeding and reproductive plans

Disclose pregnancy, breastfeeding or plans that may affect medicine decisions. Nily must apply the current approved prescribing information and clinical protocol rather than offering a generic automated answer.

Eating patterns, mental wellbeing and safety

Discuss restrictive eating, bingeing, purging, body-image distress, depression, anxiety or another relevant concern without shame. A medicine funnel must not override eating-disorder or mental-health safety needs.

Examination and laboratory needs

The clinician decides whether remote assessment is sufficient and whether specific examination, records or tests are relevant. No fixed package should be forced on every visitor.

Ability to continue and follow up safely

Consider affordability, access, administration, storage, monitoring and what happens if the medicine is unavailable or stopped. Starting without a realistic continuity plan can create harm and waste.

How the Nily GLP-1 evaluation pathway works

Step 1

Complete an optional readiness check

Organize questions and identify information that may be useful. The core result must appear before optional account creation and must not label someone eligible or ineligible. Start the Free GLP-1 Readiness Check

Step 2

Check verified clinician availability

See only clinicians whose current qualification, registration, jurisdiction, consultation scope and schedule support the service.

Step 3

Review scope, fee and terms

Before payment, see the clinician's identity, mode, duration, fee, taxes, cancellation terms, whether follow-up is included and which services or medicine costs are separate. Before booking a GLP-1 doctor consultation, verify the clinician's name, qualification, registration details, scope, consultation fee and current availability.

A thorough evaluation typically considers your weight history, BMI context and, where relevant, waist circumference alongside broader health history—not a single number in isolation.

Step 4

Complete protected clinical intake and consent

Provide identity, health history, medicines and relevant records through the protected flow. Teleconsultation consent, health-data processing and marketing permission must remain separate.

Step 5

Attend the individual evaluation

The clinician reviews the available information, asks follow-up questions and determines whether online evaluation is sufficient or in-person assessment is needed.

Step 6

Receive an appropriate outcome

The outcome may be that the medicine is not appropriate, more information is needed, another approach should be considered, or a current approved medicine may be prescribed within lawful scope. No outcome is guaranteed.

Step 7

Use a monitored follow-up plan

If a medicine is prescribed, the plan should define instructions, education, monitoring, side-effect escalation, follow-up and who to contact. Medicine purchase must remain separate and transparent.

Possible evaluation outcomes

Not appropriate at this time

The clinician may advise against a GLP-1 or related medicine based on current information, approved use, risk, examination needs or another priority.

More information or in-person care needed

The clinician may request records, targeted tests or physical assessment. This is a clinical outcome, not a failed conversion.

A different weight-management pathway is more suitable

Nutrition, activity, behavioural support, sleep, mental-health care, treatment of another condition or a different clinician-led approach may be more appropriate.

A prescription is clinically and lawfully appropriate

Only the evaluating prescriber can make this decision. The prescription must identify the actual medicine, instructions and follow-up, and must not be generated or changed by a sales workflow.

Bring useful information—not a perfect record

If available and relevant, prepare:

  • Your goals, priorities and questions.
  • Current weight and recent trend without manipulating measurements for eligibility.
  • Diagnosed conditions, operations and significant medical history.
  • Current medicines, supplements, allergies and previous reactions.
  • Previous weight-management medicines and why they were stopped.
  • Relevant recent laboratory reports or clinician notes.
  • Pregnancy, breastfeeding or reproductive-plan context where applicable.
  • Eating-disorder, mental-health or substance-use context relevant to safe care.
  • Budget, access and follow-up constraints.

Do not delay urgent care to complete intake. Do not email reports or health details through the public contact address.

A brand request is not a prescribing decision

You may ask about Mounjaro, Wegovy, Ozempic, tirzepatide, semaglutide or another medicine you have encountered. The clinician must consider the exact product, current CDSCO-approved indication and form, evidence, contraindications, alternatives, availability and your individual context.

Nily must not:

  • Present different medicines or brands as interchangeable.
  • Use a diabetes brand page to imply approval for every weight-management use.
  • Guarantee a brand, dose, prescription or pharmacy stock.
  • Recommend off-label use through an automated result or public page.
  • Substitute a medicine or form after prescription without lawful prescriber and patient review.
  • Rank clinicians by prescribing or conversion rate.

Current India approval information must be verified against the official CDSCO source at publication and every material update.

Evaluation, medicine and ongoing support have separate costs

Pricing

Free with your program

  • The clinician-led evaluation is included free with your Nily program
  • Medicine, lab tests and delivery are always separate and shown before payment — never bundled into the evaluation
  • A free evaluation never guarantees a prescription; the clinician makes the individual decision

Free covers the clinical evaluation when you are on a Nily program. Without a program, the evaluation fee is shown at booking before payment. Medicine and tests are charged separately by the licensed provider.

256-bit AES encryption at rest · TLS in transit. Your health data never leaves the people you trust.

Before booking, show the evaluation fee, taxes, included follow-up and cancellation terms. If tests, medicine, delivery, supplies, program access or later consultations are separate, state that clearly before payment.

Do not use a low consultation price to conceal mandatory downstream charges. Do not publish a static medicine price that can become inaccurate or imply that the most expensive option is clinically superior.

What can a weight-loss injection pathway cost?

A weight-loss injection price is not the same as the total pathway cost, and paying for an evaluation does not guarantee a prescription. Each part below is priced and shown separately once live:

Clinical evaluation fee Free with your Nily program; otherwise shown at booking, before payment.
Laboratory tests, if recommended Charged separately, only when ordered—see Metabolic Laboratory Tests.
Medicine price Set by the licensed pharmacy for the exact approved product—verified at fulfilment, never a fixed number here.
Ongoing support program Optional, priced separately—see GLP-1 Support Program.

Laboratory tests must have a reason

Some people may need selected baseline or follow-up information; others may already have suitable current records. The clinician determines what is relevant. Nily must not automatically sell the largest metabolic panel to every consultation visitor.

Compare Metabolic Laboratory Tests

Prescription and pharmacy fulfilment must remain independent

A clinical decision cannot be conditional on buying medicine from Nily or a preferred pharmacy. If fulfilment is offered, show the licensed seller, prescription validation, exact product, quantity, price, taxes, delivery, storage, substitution and return limitations separately.

Avoid:

  • Unverified sellers and counterfeit products.
  • Shared pens or vials and products without traceable packaging.
  • Social-media offers.
  • Using someone else's prescription or medicine.

Ongoing support begins after an appropriate plan exists

If a clinician prescribes treatment, track the actual instructions, administration, appetite and intake, selected symptoms, weight trends, relevant measurements and follow-up questions without treating the app as the prescriber.

Side effects need direct escalation—not engagement tactics

Possible side effects and serious risks depend on the specific medicine and current prescribing information. Nily must show product-specific education only after the exact medicine is known and must not use a generic reassurance chatbot as the safety system.

Contact the responsible clinician or appropriate urgent service when symptoms are concerning, persistent or worsening. For severe abdominal pain, repeated vomiting or inability to keep fluids down, major breathing difficulty, facial or throat swelling, fainting, confusion, a seizure or another possible emergency, call 112 or seek emergency care.

Read Nily's Medication Safety Guidance

Privacy for weight, medicine and clinical information

Your health is not a marketer’s wealth — we sell health, not your data.

Weight, diagnoses, medicine interest, reproductive context, eating patterns, mental-health information, laboratory reports, consultation notes and prescription outcomes are sensitive. Nily must not use them for advertising audiences, lead scoring, body-based targeting, insurer or employer decisions, or general session replay.

Explain what the clinician, laboratory, pharmacy, payment processor and authorized Nily roles can access and why.

For non-urgent product, privacy, booking or billing questions, email care@nily.health. Do not email symptoms, prescriptions or emergencies.

Check GLP-1 clinical evaluation availability

Use the live module to see whether an appropriately qualified clinician is currently available for your location and broad need.

Availability check — not yet live

This module will show only verified clinician options once a qualified clinician, legal scope, protocol, fee schedule and fulfilment control are confirmed operational. Until then, checking availability here does not create a booking, a lead or a marketing contact.

First-step fields (once live)

  • Your location: state or union territory, plus city or postcode only where needed for jurisdiction and serviceability.
  • Patient age group: adult or minor. An adult medicine pathway is not shown to a minor unless a separately approved service and protocol exist.
  • Broad need: weight-management medicine discussion, existing-prescription follow-up, adverse-effect review or another currently supported scope.
  • Preferred language and consultation mode: only current verified options are shown.
  • Emergency confirmation: "I understand this service is not for emergencies," with direct 112 access beside it.

How this module will behave

  • Collect only coarse matching information before showing availability; detailed clinical intake follows provider selection and consent.
  • Show the clinician's verified identity, qualification, registration, jurisdiction, scope, mode, language, duration, time, fee and platform relationship.
  • Show what is included and excluded, including whether follow-up is separate.
  • Never display "eligible," a medicine recommendation or a prescription probability.
  • Never promise a brand, dose, test or medicine stock.
  • If no appropriate clinician is available, say so clearly and offer non-commercial education or general care navigation.
  • Checking availability will not create a marketing lead; marketing requires separate consent.
  • Emergency indicators stop the booking funnel and show direct urgent actions.

Frequently asked questions

What is a GLP-1 clinical evaluation?

It is an individual consultation in which an appropriately qualified clinician reviews whether a prescription weight-management medicine pathway may be appropriate and what information, examination, monitoring or alternatives are needed.

Does the free readiness check tell me whether I qualify?

No. It helps you prepare for a discussion. It cannot diagnose, confirm eligibility, select medicine or replace a clinician.

Does booking guarantee a prescription?

No. The clinician may decide that medicine is not appropriate, more information or in-person care is needed, or another pathway is preferable.

Can I ask for Mounjaro, Wegovy or Ozempic?

You may ask about a medicine, but the request does not determine the decision. The clinician must use the exact product's current Indian approval, prescribing information, availability and your individual context.

Is a GLP-1 medicine only for diabetes?

Approved uses differ by exact medicine, brand, formulation and jurisdiction and can change. The live clinical workflow must use current CDSCO-approved information for the actual product.

Can I get a weight-loss injection online?

An online evaluation may be possible where a qualified clinician and appropriate service are available. The clinician may still require examination, tests or in-person care, and a prescription is not guaranteed.

How much does the evaluation cost?

The clinical evaluation is free when you are on a Nily program. Without a program, the consultation fee, taxes, inclusions and terms are shown before booking. Tests, medicine, delivery and follow-up are always itemized separately — the evaluation is never a shortcut to a prescription.

How much does GLP-1 medicine cost in India?

Price depends on the exact approved product, form, strength, seller and current market. Nily must show a verified current price only in a lawful fulfilment flow, not as a static promise on this page.

Will I need blood tests?

Not automatically. The clinician decides whether existing records are sufficient or selected tests are relevant. The largest package must not be a mandatory sales step.

Can a nutritionist prescribe GLP-1 medicine?

Do not assume so. Prescribing requires an appropriately qualified and registered prescriber acting within current legal and professional scope.

Can I use the service during pregnancy or breastfeeding?

Disclose pregnancy, breastfeeding and relevant plans before any medicine decision. The clinician must apply the current product information and appropriate clinical guidance.

What if I already have a prescription?

Provide the current prescription and prescriber details through the protected flow. Nily must not renew, change or substitute it automatically.

What if I experience side effects?

Follow the product-specific plan and contact the responsible clinician for concerning, persistent or worsening symptoms. Use emergency care for severe symptoms or immediate danger.

Does Nily sell GLP-1 medicine?

Any future fulfilment must identify the licensed seller, exact product, prescription requirement, price and terms. A consultation cannot be conditional on buying through Nily.

How can I contact Nily?

Email Info@annotatory.com for non-urgent product, privacy, booking, billing or partnership enquiries.

Check the evaluation scope before sharing detailed health information

Review the clinician's verified identity, scope, fee, format and terms, then decide whether a GLP-1 clinical evaluation is the right next step.

The evaluation supports an individual clinical decision. It does not guarantee medicine, a prescription or a weight-loss outcome.

Questions? Email care@nily.health.